Bulk Suggestion
Bulk ID:
braviboron/09.15.25-05:45AM
Accepted at: Sep, 19, 2025
9:28 p.m.
Author:
braviboron
Co-authors:
mohsenz22
Related Deck:
1675118865074
Accepted
Rationale for new note
Personality disorders
Text
When may pharmacotherapy be considered in personality disorder?
{{c1::When symptoms are severe, impairing, or unresponsive to psychosocial interventions}}
{{c1::When symptoms are severe, impairing, or unresponsive to psychosocial interventions}}
Text
When may <u>pharmacotherapy</u> be considered in <b>personality disorder</b>?<br><br>{{c1::When symptoms are severe, impairing, or unresponsive to psychosocial interventions}}
Extra
Before considering pharmacotherapy to target symptom(s) of personality disorder, consider if the symptom(s) could be caused by a co-occurring psychiatric disorder (e.g. a psychotic, depressive, bipolar, or anxiety disorder).
Extra
<span style="color: rgb(65, 64, 66); font-family: FranklinGothicITCbyBT-Book, sans-serif; font-size: 14px;">Before considering pharmacotherapy to target symptom(s) of personality disorder, consider if the symptom(s) could be caused by a co-occurring psychiatric disorder (e.g. a psychotic, depressive, bipolar, or anxiety disorder).</span><br>
Extra (Synced)
Empty field
Extra (Synced)
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
eTG Complete
Empty field
eTG Complete
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Additional Resources (Synced)
Source
eTG - Personality disorder https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Psychotropic&topicfile=personality-disorder&guidelinename=Psychotropic§ionId=toc_d1e195#toc_d1e195 Published/Amended March 2021, Accessed 13 September 2025
Source
eTG - Personality disorder <a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Psychotropic&topicfile=personality-disorder&guidelinename=Psychotropic§ionId=toc_d1e195#toc_d1e195">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Psychotropic&topicfile=personality-disorder&guidelinename=Psychotropic&sectionId=toc_d1e195#toc_d1e195</a> Published/Amended March 2021, Accessed 13 September 2025
One by one
Empty field
One by one
Tags
#Malleus_CM::#eTG_Complete::Psychotropic::Personality_disorder
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Resources_by_Rotation::Psychiatry
#Malleus_CM::#Subjects::Psychiatry::02_Psychotic_Disorders::Schizotypal_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::01_Cluster_A::Paranoid_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::01_Cluster_A::Schizoid_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::01_Cluster_A::Schizotypal_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::02_Cluster_B::Antisocial_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::02_Cluster_B::Borderline_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::02_Cluster_B::Histrionic_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::02_Cluster_B::Narcissistic_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::03_Cluster_C::Avoidant_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::03_Cluster_C::Dependent_Personality_Disorder::10_Management
#Malleus_CM::#Subjects::Psychiatry::09_Personality_Disorders::03_Cluster_C::Obsessive-Compulsive_Personality_Disorder::10_Management
#Malleus_CM::#Yield::Medium